April 18, 2022 — A jury in Ohio has awarded $250,000 to a man who needed multiple surgeries for problems with his Ventralex Hernia Patch.
The lawsuit was filed by Antonio M., a man who had a Ventralex Hernia Patch implanted in 2007. According to the complaint, he needed multiple “surgical interventions” due to serious complications.
Those complications included an infection and a bowel abscess, which needed another surgery in 2017.
After an 18-day trial, the federal jury in Columbus, Ohio, awarded him $250,000 in compensation after finding that Bard and Davol Inc. were negligent for selling a defectively designed medical device.
It is the second case to go to trial in the Multi-District Litigation (MDL) in Ohio. Back in September, another jury found that Bard and Davol were not liable for a lawsuit involving Ventralight ST hernia mesh.
The federal MDL that now involves nearly 16,700 cases, making it the 3rd-largest in the nation. Around 10,000 additional lawsuits have also been coordinated in Rhode Island state court.
All of the plaintiffs allege that the mesh implants are defective due to the use of polypropylene, a synthetic material that can degrade in the body and cause serious infections, immune reactions, and more.
The lawsuit was filed in the U.S. District Court for the Southern District of Ohio — Multi-District Litigation (MDL 2846) — In re: Davol Inc./C.R. Bard Inc. Polypropylene Hernia Mesh Products Liability Litigation.
Do I have a Ventralex Hernia Patch Lawsuit?
The Schmidt Firm, PLLC is currently accepting hernia patchcontact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Medical Device Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.